SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

CSPC Pharmaceutical 9M Profit Jumps on AstraZeneca Licence Fee

CSPC Pharmaceutical's nine-month profit rose, helped by an AstraZeneca licence fee.

Related stories